+924.9%
MRNA vs RBRK
+46.1%
+878.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RBRK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -11.1% | +4.6% | -4.3% |
| 7D | +8.4% | -20.9% | +29.3% | +13.2% |
| 30D | +28.8% | -15.9% | +44.8% | +32.9% |
| 3M | +329.2% | +24.7% | +304.5% | +306.8% |
| 6M | +416.9% | +85.1% | +331.8% | +341.5% |
| YTD | +718.8% | +38.3% | +680.5% | +673.4% |
| 1Y | +924.9% | +46.2% | +878.7% | +837.2% |
| All | +924.9% | +46.1% | +878.8% | +837.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RBRK.
Daily Out/Under-Performance
Portfolio return minus RBRK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RBRK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RBRK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling